Cargando…

Corrigendum: Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells

Detalles Bibliográficos
Autores principales:	Dwivedi, Alka, Karulkar, Atharva, Ghosh, Sarbari, Rafiq, Afrin, Purwar, Rahul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418378/ https://www.ncbi.nlm.nih.gov/pubmed/30906295 http://dx.doi.org/10.3389/fimmu.2019.00401

Ejemplares similares

Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells
por: Dwivedi, Alka, et al.
Publicado: (2019)

Immunogenicity of CAR-T Cell Therapeutics: Evidence, Mechanism and Mitigation
por: Khan, Aalia N., et al.
Publicado: (2022)

Hydrogel scaffold with substrate elasticity mimicking physiological-niche promotes proliferation of functional keratinocytes
por: Mogha, Pankaj, et al.
Publicado: (2019)

Corrigendum: Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
por: Feng, Qiang, et al.
Publicado: (2022)

Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
por: Kilgour, Marisa K., et al.
Publicado: (2023)

CAR T Cell Therapy for Neuroblastoma
por: Richards, Rebecca M., et al.
Publicado: (2018)

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
por: Martínez Bedoya, Darel, et al.
Publicado: (2021)

CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
por: Ferreira, Leonardo M. R., et al.
Publicado: (2021)

CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells
por: Thomas, Simone, et al.
Publicado: (2023)

Advances in Universal CAR-T Cell Therapy
por: Lin, Haolong, et al.
Publicado: (2021)

Reactions Related to CAR-T Cell Therapy
por: Miao, Lele, et al.
Publicado: (2021)

Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy
por: Chen, Wei, et al.
Publicado: (2021)

Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
por: Ramírez-Chacón, Alejandro, et al.
Publicado: (2022)

Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy
por: Li, Wenshuai, et al.
Publicado: (2023)

Corrigendum: Ontogeny of Innate T Lymphocytes – Some Innate Lymphocytes Are More Innate Than Others
por: Vermijlen, David, et al.
Publicado: (2015)

Corrigendum: Lymphocyte Autophagy in Homeostasis, Activation, and Inflammatory Diseases
por: Arbogast, Florent, et al.
Publicado: (2018)

Editorial: Lymphocyte Functional Crosstalk and Regulation
por: Srivastava, Raghvendra M., et al.
Publicado: (2019)

Corrigendum: Unperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Theorell, Jakob, et al.
Publicado: (2019)

The Potential of CAR T Cell Therapy in Pancreatic Cancer
por: Akce, Mehmet, et al.
Publicado: (2018)

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
por: Watanabe, Keisuke, et al.
Publicado: (2018)

Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL
por: Jeyakumar, Nikeshan, et al.
Publicado: (2022)

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer
por: Wu, Yanan, et al.
Publicado: (2023)

Corrigendum: Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

Impact of Manufacturing Procedures on CAR T Cell Functionality
por: Watanabe, Norihiro, et al.
Publicado: (2022)

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
por: Zhou, Ru, et al.
Publicado: (2020)

Advances in Developing CAR T-Cell Therapy for HIV Cure
por: Qi, Jinxin, et al.
Publicado: (2020)

Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
por: Lindo, Lorenzo, et al.
Publicado: (2021)

The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies
por: Guo, Zilong, et al.
Publicado: (2021)

Recent advances in CAR-T cells therapy for colorectal cancer
por: Qin, Xiaoling, et al.
Publicado: (2022)

Clinical Investigations of CAR-T Cell Therapy for Solid Tumors
por: Chen, Kun, et al.
Publicado: (2022)

Prospective approaches to enhancing CAR T cell therapy for glioblastoma
por: Choi, Sun Il, et al.
Publicado: (2022)

Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy
por: Lv, Zixin, et al.
Publicado: (2023)

Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt’s lymphoma with TP53 mutations
por: Zhang, Qi, et al.
Publicado: (2023)

Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
por: Ruppel, Katharina Eva, et al.
Publicado: (2022)

The altering cellular components and function in tumor microenvironment during remissive and relapsed stages of anti-CD19 CAR T-cell treated lymphoma mice
por: Zhao, Kai, et al.
Publicado: (2023)

Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances
por: Liu, Jile, et al.
Publicado: (2023)

Diversity, function, and transcriptional regulation of gut innate lymphocytes
por: Rankin, Lucille, et al.
Publicado: (2013)

Regulation of Inflammatory Functions of Macrophages and T Lymphocytes by NFAT5
por: Aramburu, Jose, et al.
Publicado: (2019)

The Actin Regulators Involved in the Function and Related Diseases of Lymphocytes
por: Sun, Jianxuan, et al.
Publicado: (2022)

TOX regulates T lymphocytes differentiation and its function in tumor
por: Niu, Haiyue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ojvtpfc1geghr7qhd3vdfga1n